Despite short-term contraction caused by the ongoing COVID-19 pandemic, as well as delays in the availability of new technologies due to strict regulations and the use of alternative treatments, the Japanese market for interventional oncology devices will grow moderately over the forecast period due to an expanding patient pool, the increasing adoption of minimally invasive techniques, and the introduction and adoption of premium-priced devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across a 10-year period.


The COVID-19 pandemic will affect the interventional oncology device market in the short term.

How will COVID-19 affect procedure volumes?

What impact will the pandemic have on market dynamics?

Alternative forms of treatment are commonly used to treat cancer in Japan.

What alternatives compete with interventional oncology devices?

What impact will these treatments have on the interventional oncology device market?

Gelatin sponges represent a large portion of the Japanese embolization device market.

What factors will contribute to the adoption of different embolization particles for the treatment of both primary and secondary liver cancer?

Which companies represent the major players in the embolization device market?

Radioembolization spheres have not yet been approved in Japan.

When are radioembolization spheres expected to be launched in Japan?

What impact will the launch of these devices have on the overall market?

Table of contents

  • Japan
    • Abstract
    • Executive Summary
      • COVID-19 Updates
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Average Currency Exchange Rates
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • COVID-19 Analysis
      • Market Impact
      • Guidance and Recommendations
      • Major Market Forecast Changes and Assumptions
      • Competitive Impact
    • Interventional Oncology Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Portfolio Management
        • Reimbursement
        • Regulatory Environment
        • Distribution and Sales Network
        • Physician Training and Marketing
        • Product Improvements and Innovations
      • Market Developments
    • Ablation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Radiofrequency Ablation Devices
        • Microwave Ablation Devices
        • Cryoablation Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Embolization Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Radioembolization Spheres
        • Drug-Eluting Beads
        • Microspheres
        • Gelatin Sponge
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Product Improvements and Innovations
    • Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Pankhil Gandhi, PharmD

Pankhil Gandhi is a research associate within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.


Related Reports

Interventional Oncology Devices | Medtech 360 | Market Insights | Europe

European interventional oncology device procedure volumes and revenues will grow moderately, driven by an expanding patient population, rising patient and physician awareness, improved reimburse...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Latin America

The Latin American interventional oncology device market will see moderate growth, driven by an increasing patient population, adoption of premium-priced devices, and the introduction of new dev...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treat...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | United States

The US market for interventional oncology devices continues to grow, driven by expanding treatable patient populations and increasing uptake of premium-priced technology. However, growth in...

View Details